The rise of a highly litigious environment is gaining momentum in Canada, resulting in significant growth in risk for organizations in every aspect of their business and in every sector of the economy. Topics discussed include the risks associated with commercial practices such as procurement and data protection, through to project management and the rise of securities and consumer class actions.
This latest edition of our popular Capital Markets series identifies the key developments of the past year and features our lawyers’ insights into the trends that we believe will shape Canadian and global capital markets in 2014.
On June 4, 2014, the first budget (Budget) of the new Liberal government, in power since April 7, 2014, was tabled in the Québec National Assembly. The Budget provides for certain measures to relaunch the Plan Nord, as announced by the Liberals during the latest election campaign.
In two nearly identical decisions the Federal Court of Canada held that generic pharmaceutical patent licensees are not subject to the jurisdiction of the Patented Medicines Prices Review Board, including its powers to regulate drug prices. These decisions, which may be appealed to the Federal Court of Appeal, mark a retreat from the courts’ expansive views about the jurisdiction of the PMPRB.
Osler Financial Services Law Blog: timely analysis, updates and discussion on Canadian and U.S./cross-border credit market developments.